The study was carried out on healthy subjects but could have future implications for intensive care unit (ICU) patients, researchers said.
Melatonin is the hormone secreted by the body to regulate sleep, usually in periods of darkness.
Synthetically produced melatonin is used to boost the body's own melatonin levels to treat some sleep disorders, and sometimes as a means of overcoming jet lag.
In ICUs, disturbances throughout the night, caused by noise and light, have been linked to slower recovery. This has led clinicians to investigate ways of reducing sleep disturbances.
The research was conducted in the sleep lab of Fuzhou Children's Hospital of Fujian Province in collaboration with Professor Ling Shen. For the first four nights all participants underwent a baseline/adjustment period.
During this time they slept in a sleep laboratory where on alternating nights, a recording from a typical night shift at an ICU was played and light levels were the same as in the hospital.
After the first four nights, the participants were randomly divided into four equal groups but continued to sleep in the simulated ICU.
The final group of participants was given a placebo. The participants did not know if they were receiving melatonin or placebo.
During the study period all participants' melatonin levels were tested hourly by taking blood samples.
Anxiety levels and sleep quality were also evaluated by getting participants to self-evaluate the following morning.
It was found that all sleep patterns were disturbed by exposure to the simulated ICU environment. This resulted in feelings of anxiety and reduced quality of sleep.
Those who took melatonin were found to have decreased awakenings during the night even compared to the eye mask and earplugs group.
The quality of the sleep was also found to be much improved for those taking melatonin, with reported lower anxiety levels and increased REM sleep - thought to be linked to improved cognitive restoration.
The study was published in the journal Critical Care.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
